BioPharma Credit PLC (LON:BPCR)

BioPharma Credit Revenue

BioPharma Credit had revenue of $57.42M USD in the half year ending June 30, 2026, a decrease of -27.45%. This brings the company's revenue in the last twelve months to $131.40M, down -15.05% year-over-year. In the year 2025, BioPharma Credit had annual revenue of $157.78M with 5.17% growth.

• Revenue (ttm): $131.40M
• Revenue Growth: -15.05%
• P/S Ratio: 7.04
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 825.19M GBP

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	157.78M	7.76M	5.17%
Dec 31, 2024	150.03M	14.30M	10.53%
Dec 31, 2023	135.73M	-82.41M	-37.78%
Dec 31, 2022	218.14M	114.28M	110.03%
Dec 31, 2021	103.86M	-6.15M	-5.59%
Dec 31, 2020	110.01M	-40.89M	-27.10%
Dec 31, 2019	150.89M	53.61M	55.11%
Dec 31, 2018	97.28M	-	-

Data Source: Fiscal.ai Last updated: Sep 23, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 25, 2026

Data Sources Report a data error